Skip to main content

Viridian Therapeutics, Inc.

VRDN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001590750

In the last 90 days, Viridian Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 214 institutions reported holding it in 13F filings for Q2 2026, worth $2.50B in total; no superinvestor holds it.

13F holders, Q3 2021

Institutional positions in Viridian Therapeutics, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
39
+13 vs. Q2 2021
Shares held
13.6M
+7.60M (+126.5%) vs. Q2 2021
Total value
$223.7M
+$113.9M (+103.7%) vs. Q2 2021
New holders
16
16 more added
Sold out
3
3 more reduced

Compare with Q2 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting VRDN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2021: 39 institutions
Q1 2021: 33 institutionsQ2 2021: 26 institutionsQ3 2021: 39 institutionsQ4 2021: 55 institutionsQ1 2022: 72 institutionsQ2 2022: 84 institutionsQ3 2022: 105 institutionsQ4 2022: 122 institutionsQ1 2023: 135 institutionsQ2 2023: 128 institutionsQ3 2023: 124 institutionsQ4 2023: 132 institutionsQ1 2024: 136 institutionsQ2 2024: 138 institutionsQ3 2024: 165 institutionsQ4 2024: 179 institutionsQ1 2025: 177 institutionsQ2 2025: 171 institutionsQ3 2025: 169 institutionsQ4 2025: 229 institutionsQ1 2026: 225 institutionsQ2 2026: 214 institutions
Value heldQ3 2021: $223.7M
Q1 2021: $84.5MQ2 2021: $109.8MQ3 2021: $223.7MQ4 2021: $459.8MQ1 2022: $460.9MQ2 2022: $327.7MQ3 2022: $778.5MQ4 2022: $1.21BQ1 2023: $1.10BQ2 2023: $1.12BQ3 2023: $769.9MQ4 2023: $1.31BQ1 2024: $1.24BQ2 2024: $906.2MQ3 2024: $1.98BQ4 2024: $1.75BQ1 2025: $1.23BQ2 2025: $1.32BQ3 2025: $2.01BQ4 2025: $3.36BQ1 2026: $2.21BQ2 2026: $2.50B
Institutions holding VRDN and their total value by quarter
QuarterHoldersValue
Q2 2026214$2.50B
Q1 2026225$2.21B
Q4 2025229$3.36B
Q3 2025169$2.01B
Q2 2025171$1.32B
Q1 2025177$1.23B
Q4 2024179$1.75B
Q3 2024165$1.98B
Q2 2024138$906.2M
Q1 2024136$1.24B
Q4 2023132$1.31B
Q3 2023124$769.9M
Q2 2023128$1.12B
Q1 2023135$1.10B
Q4 2022122$1.21B
Q3 2022105$778.5M
Q2 202284$327.7M
Q1 202272$460.9M
Q4 202155$459.8M
Q3 202139$223.7M
Q2 202126$109.8M
Q1 202133$84.5M

Institutions, Q3 2021

Shares, value and share of portfolio for each institution holding Viridian Therapeutics, Inc.; share changes are against Q2 2021.

Institutions holding VRDN in Q3 2021
InstitutionSharesValue% of portfolioChange in sharesAction
Frazier Management LLC1,505,200$24.8M1.98%+1,505,200New
Logos Global Management LP1,500,000$24.7M1.78%+1,500,000New
Perceptive Advisors LLC1,423,000$23.4M0.34%+628,494+79.1%Added
Vivo Capital, LLC1,300,000$21.4M0.96%+1,300,000New
Fairmount Funds Management LLC944,092$15.5M5.65%+909,000+2,590.3%Added
Ally Bridge Group (NY) LLC904,978$14.9M4.88%+45,068+5.2%Added
BVF Inc804,126$13.2M0.52%+454,045+129.7%Added
D. E. Shaw & Co., Inc.720,530$11.9M0.02%+1570.0%Added
Commodore Capital LP667,674$11.0M2.90%+481,269+258.2%Added
Point72 Asset Management, L.P.610,000$10.0M0.05%+214,466+54.2%Added
Franklin Resources Inc600,000$9.87M0.00%+600,000New
Vanguard Group Inc461,912$7.60M0.00%+107,846+30.5%Added
Ghost Tree Capital, LLC350,000$5.76M1.90%00.0%Unchanged
Cormorant Asset Management, LP342,562$5.63M0.23%−400−0.1%Reduced
Atlas Venture Advisors, Inc.209,505$3.45M0.41%00.0%Unchanged
Millennium Management LLC161,345$2.65M0.00%+43,630+37.1%Added
Eversept Partners, LP160,000$2.63M0.21%+160,000New
Maven Securities LTD140,000$2.30M0.26%+140,000New
Acuta Capital Partners, LLC135,807$2.23M0.80%+135,807New
Silverarc Capital Management, LLC106,078$1.75M1.01%+77,679+273.5%Added
Marshall Wace North America L.P.75,000$1.23M0.01%+75,000New
Geode Capital Management, LLC61,250$1.01M0.00%+22,967+60.0%Added
Polar Asset Management Partners Inc.59,700$982.0K0.01%+59,700New
Pura Vida Investments, LLC58,096$956.0K0.07%+58,096New
BlackRock Inc.50,841$836.0K0.00%+589+1.2%Added
Driehaus Capital Management LLC50,000$823.0K0.01%+50,000New
Schonfeld Strategic Advisors LLC44,000$724.0K0.01%+44,000New
Northern Trust Corp34,651$570.0K0.00%+3,184+10.1%Added
LMR Partners LLP33,508$551.0K0.01%+33,508New
State Street Corp23,841$392.0K0.00%+12,800+115.9%Added
Walleye Capital LLC22,501$370.0K0.01%+22,501New
VR Adviser, LLC19,495$321.0K0.04%00.0%Unchanged
Morgan Stanley9,922$163.0K0.00%+2,937+42.0%Added
Walleye Trading LLC7,500$123.0K0.00%+7,500New
UBS Group AG1,443$24.0K0.00%+1,430+11,000.0%Added
Ra Capital Management, L.P.1,034$17.0K0.00%−311,294−99.7%Reduced
Wells Fargo & Company412$7.00K0.00%−107−20.6%Reduced
Bank of America Corp173$3.00K0.00%+173New
GPS Wealth Strategies Group, LLC3$00.00%00.0%Unchanged
Wellington Management Group LLP0$00.00%−578,560−100.0%Sold out
Balyasny Asset Management LLC0$00.00%−119,478−100.0%Sold out
Bailard, Inc.0$00.00%−90,500−100.0%Sold out